Javier Rodriguez - 30 Apr 2026 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Reporting relationship: Director
Issuer ticker: GILD
Reported as of: 30 Apr 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 04 May 2026, 16:25:01 UTC
Prior SEC filing: 17 Mar 2026
Next SEC filing: 17 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Amy Kim by Power of Attorney for Javier J. Rodriguez

Key filing fact

Javier Rodriguez filed Form 4 for GILEAD SCIENCES, INC. (GILD) on 04 May 2026.

Key facts

This page summarizes Javier Rodriguez's Form 4 filing for GILEAD SCIENCES, INC. (GILD).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 04 May 2026, 16:25.

Change

Previous filing in this sequence was filed on 17 Mar 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001415548 Primary reporting owner

Rodriguez Javier

Relationship: Director
Address: 333 LAKESIDE DRIVE, FOSTER CITY
Signature: /s/ Amy Kim by Power of Attorney for Javier J. Rodriguez
Signature date: 04 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

GILD transaction

Common Stock

Award

Transaction value
Shares: +1,146
Change %: +9.4%
Price: $0.000000^*
Shares after: 13,364
Date: 30 Apr 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

GILD transaction Derivative

Non-qualified Stock Option (Right to Buy)

Award

Transaction value
Shares: +4,884
Change %
Price: $0.000000^*
Shares after: 4,884
Date: 30 Apr 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 4,884
Exercise price: $130.84
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents 1,146 restricted stock units ("RSUs") granted under the Gilead Sciences, Inc. 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. The RSUs vested immediately upon the grant date of April 30, 2026.

Footnote F2

100% of the shares subject to the stock option vested immediately upon the grant date of April 30, 2026.